Brief: Redcare Pharmacy Raises 2026 FY Outlook
15/06/2026 15:18
BRIEF-Redcare Pharmacy Raises 2026 FY Outlook June 15 (Reuters) - Redcare Pharmacy NV RDC.DE:
EQS-ADHOC: REDCARE PHARMACY REPORTS STRONGER THAN EXPECTED Q2 2026 QUARTER-TO-DATE TRADING AND RAISES ITS FULL-YEAR 2026 OUTLOOK.
SEES 2026 NON-RX GROWTH OF 10%-12% (PREV 8%-10%)
SEES 2026 ADJUSTED EBITDA MARGIN 2.5%-3% (PREV IN EXCESS OF 2.5%)
Source text: ID:nEQ4zcrkLa
Further company coverage: RDC.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Redcare Pharmacy NV
See all newsNetherlands' Redcare Pharmacy slightly beats Q3 revenue estimates on strong prescription sales in Germany
Brief: Redcare Pharmacy Q3 Sales EUR 847 Million
Brief: Redcare Pharmacy Appoints Peter Schmid Von Linstow As CEO
Europe Research Roundup: DEUTZ, Legrand, VAT
Brief: Redcare Pharmacy Now Expects FY Total Revenue Growth of 16% to 18%